Literature DB >> 2804539

Effects of yohimbine on submaxillary salivation in dogs.

P Montastruc1, M Berlan, J L Montastruc.   

Abstract

1. The effects of yohimbine (0.5 mg kg-1 i.v.) on both resting and parasympathetic and sympathetic stimulation-induced submaxillary salivary responses were investigated in the anaesthetized dog. 2. Salivary secretion was increased significantly for a period of 45 min following an injection of yohimbine. 3. Sectioning of the chorda tympani (but not the cervical sympathetic) nerve abolished the yohimbine-induced increase in resting salivary secretion and potentiated that elicited by electrical stimulation of the chorda tympani nerve. 4. These results show that yohimbine increases submaxillary secretion by inhibition of presynaptic alpha 2-adrenoceptors located on the chorda tympani, which inhibit cholinergic transmission.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804539      PMCID: PMC1854671          DOI: 10.1111/j.1476-5381.1989.tb16868.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.

Authors:  M Taouis; M Berlan; P Montastruc; M Lafontan
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

Review 2.  Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

3.  The inhibitory effect of guanabenz on submandibulary salivation induced by chorda tympani stimulation in anaesthetized cat.

Authors:  M Terzić; D Stojić
Journal:  J Pharmacol       Date:  1986 Oct-Dec

Review 4.  Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.

Authors:  M R Goldberg; D Robertson
Journal:  Pharmacol Rev       Date:  1983-09       Impact factor: 25.468

5.  The effect of clonidine on centrally and peripherally evoked submaxillary salivation.

Authors:  G J Green; H Wilson; M S Yates
Journal:  Eur J Pharmacol       Date:  1979-01-15       Impact factor: 4.432

6.  Urethane interferes with the alpha 2-agonist guanfacine.

Authors:  N D Moore; M Chadelaud; A M Huchet; C Saligaut; M Daoust; J P Lhuintre; P Chrétien; F Boismare
Journal:  J Cardiovasc Pharmacol       Date:  1984 Sep-Oct       Impact factor: 3.105

7.  Effects of guanabenz and guanfacine on postsynaptic alpha 2-adrenoceptors in the rat submaxillary and parotid glands.

Authors:  M D Kaniucki; J C Elverdin; F J Stefano; C J Perec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

8.  Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.

Authors:  J M Armstrong; F Lefèvre-Borg; B Scatton; I Cavero
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

9.  The pharmacokinetics of yohimbine in man.

Authors:  J A Owen; S L Nakatsu; J Fenemore; M Condra; D H Surridge; A Morales
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors.

Authors:  M D Kaniucki; F J Stefano; C J Perec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

View more
  10 in total

1.  Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.

Authors:  H Bagheri; L Schmitt; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.

Authors:  Y Rispail; L Schmitt; M Berlan; J L Montastruc; P Montastruc
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Yohimbine and lacrimal secretion.

Authors:  H Bagheri; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

4.  Mechanisms of sympathetic enhancement and inhibition of parasympathetically induced salivary secretion in anaesthetized dogs.

Authors:  M A Lung
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

5.  Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow.

Authors:  H C Porchet; P Piletta; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways.

Authors:  J P Girolami; J L Bascands; C Pécher; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

7.  Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

Authors:  H Bagheri; P Picault; L Schmitt; G Houin; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

8.  Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.

Authors:  P Barbe; J Galitzky; D Riviere; J M Senard; M Lafontan; M Garrigues; M Berlan
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 9.  Artificial Saliva for Therapeutic Management of Xerostomia: A Narrative Review.

Authors:  Hajer Ayed Alhejoury; Lina Fouad Mogharbel; Mohammed Ahmed Al-Qadhi; Suzan Sulaiman Shamlan; Amal Fuad Alturki; Wafaa Mohammed Babatin; Renad Abdualrahman Mohammed Alaishan; Fawaz Pullishery
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.